, Tracking Stock Market Picks
Enter Symbol:
Valeant Pharmaceuticals International Inc (VRX) [hlAlert]

up 1,322.77 %

Valeant Pharmaceuticals International Inc (VRX) rated Buy with price target $63 by UBS

Posted on: Monday,  Apr 11, 2011  11:25 AM ET by UBS

UBS rated Buy Valeant Pharmaceuticals International Inc (NYSE: VRX) on 04/11/2011. Previously UBS rated Buy Valeant Pharmaceuticals International Inc (NYSE: VRX) on
03/25/2010., when the stock price was $16.51. Since then, Valeant Pharmaceuticals International Inc has gained 1322.77% as of 01/06/2016's recent price of $234.90.
If you would have followed the previous UBS's recommendation on VRX, you would have gained 1322.77% of your investment in 2113 days.

Biovail Corporation (Biovail) is a specialty pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. The Company is engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products. The Company has various research and development, clinical research, manufacturing and commercial operations located in Barbados, Canada, the United States and Puerto Rico. Its main therapeutic areas of focus are central nervous system (CNS) disorders, pain management and cardiovascular disease. The primary markets for its products are the United States and Canada. On September 16, 2008, Biovail acquired Prestwick Pharmaceuticals, Inc.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/11/2011 11:25 AM Buy
54.61 63.00
as of 12/30/2011
1 Week up  7.22 %
1 Month up  32.43 %
3 Months up  143.10 %
1 YTD down  -14.39 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/28/2010 11:25 AM Buy
21.99 29.00
3/25/2010 8:25 AM Buy
16.51 20.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy